UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Driven by Mutations: The Predictive Value of Mutation Subtype in EGFR-Mutated Non–Small Cell Lung Cancer

Journal of thoracic oncology, 2017-04, Vol.12 (4), p.612-623

2017

Link zum Volltext

Verfügbarkeit prüfen

Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

Nature communications, 2016-01, Vol.7 (1), p.10582-10582, Article 10582

2016

Link zum Volltext

Verfügbarkeit prüfen

A Natural Language Processing-Assisted Extraction System for Gleason Scores: Development and Usability Study

JMIR cancer, 2021-07, Vol.7 (3), p.e27970-e27970

2021

Link zum Volltext

Verfügbarkeit prüfen

Targeting PD-L1 for non-small-cell lung cancer

Immunotherapy, 2016-06, Vol.8 (6), p.747-758

2016

Link zum Volltext

Verfügbarkeit prüfen

Referral practices of medical oncologists to palliative care for patients with metastatic non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2016-10, Vol.34 (26_suppl), p.108-108

2016

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy in melanoma

Immunotherapy, 2018-08, Vol.10 (11), p.987-998

2018

Link zum Volltext

Verfügbarkeit prüfen

PS01.03: Referral Practices of Medical Oncologists to Palliative Care for Patients with Metastatic Non–Small Cell Lung Cancer (NSCLC)

Journal of thoracic oncology, 2016-11, Vol.11 (11), p.S271

2016

Link zum Volltext

Verfügbarkeit prüfen

PS01.03: Referral Practices of Medical Oncologists to Palliative Care for Patients with Metastatic Non–Small Cell Lung Cancer (NSCLC): Topic: Medical Oncology

Journal of thoracic oncology, 2016-11, Vol.11 (11), p.S271-S271

2016

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of First-line Immune Checkpoint Blockade Versus Carboplatin-based Chemotherapy for Metastatic Urothelial Cancer

European urology, 2019-10, Vol.76 (4), p.524-532

2019

Link zum Volltext

Verfügbarkeit prüfen

Palliative Care Referrals for Advanced Non–small-cell Lung Cancer (NSCLC): Patient and Provider Attitudes and Practices

Clinical lung cancer, 2019-05, Vol.20 (3), p.e291-e298

2019

Link zum Volltext

Verfügbarkeit prüfen

Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer

European urology, 2022-06, Vol.81 (6), p.559-567

2022

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of talazoparib and avelumab in VHL deficient clear cell renal cell carcinoma

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.347-347

2022

Link zum Volltext

Verfügbarkeit prüfen

Emerging role of nivolumab in the management of patients with non-small-cell lung cancer: current data and future perspectives

OncoTargets and therapy, 2017-01, Vol.10, p.3697-3708

2017

Link zum Volltext

Verfügbarkeit prüfen

Real-world trends in first-line checkpoint inhibitor use (CPI) in advanced urothelial cell carcinoma (aUC)

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.392-392

2019

Link zum Volltext

Verfügbarkeit prüfen

Burden of genetic testing in an academic biobank by pathological and family history-based criteria in prostate cancer (PCa)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.1576-1576

2020

Link zum Volltext

Verfügbarkeit prüfen

Carboplatin-based chemotherapy (C) versus immunotherapy (IO) in metastatic urothelial carcinoma (mUC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e16003-e16003

2019

Link zum Volltext

Verfügbarkeit prüfen

A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer

European urology oncology, 2023-11

2023

Link zum Volltext

Verfügbarkeit prüfen

Sequencing Treatment in BRAFV600 Mutant Melanoma: Anti-PD-1 Before and After BRAF Inhibition

Journal of immunotherapy (1997), 2017-01, Vol.40 (1), p.31

2017

Link zum Volltext

Verfügbarkeit prüfen

STUDIES ON CHOLINESTERASE

The Journal of biological chemistry, 1947-12, Vol.171 (2), p.715-724

1947

Link zum Volltext

Verfügbarkeit prüfen

STUDIES ON CHOLINESTERASE

The Journal of biological chemistry, 1948-05, Vol.174 (1), p.247-256

1948

Link zum Volltext

Verfügbarkeit prüfen

Rate of penetration of electrolytes into nerve-fibers

The Journal of biological chemistry, 1948-01, Vol.172 (1), p.345-346

1948

Link zum Volltext

Verfügbarkeit prüfen

Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution

Cell host & microbe, 2018-05, Vol.23 (5), p.628-635.e7

2018

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Sustained Virologic Response as a Relevant Surrogate Endpoint for Long-term Outcomes of Hepatitis C Virus Infection

Clinical infectious diseases, 2021-03, Vol.72 (5), p.780-786

2021

Link zum Volltext

Verfügbarkeit prüfen

Ombitasvir, paritaprevir, and ritonavir plus dasabuvir for 8 weeks in previously untreated patients with hepatitis C virus genotype 1b infection without cirrhosis (GARNET): a single-arm, open-label, phase 3b trial

The lancet. Gastroenterology & hepatology, 2017-07, Vol.2 (7), p.494-500

2017

Link zum Volltext

Verfügbarkeit prüfen

PO-653-08 EFFECT OF VT ABLATION ON TIME BETWEEN VT STORM AND HEART TRANSPLANT

Heart rhythm, 2022-05, Vol.19 (5), p.S257-S257

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(17)
Humans
(15)
Female
(8)
Male
(8)
Patients
(6)
Oncology
(5)
Animals
(4)
Middle Aged
(4)
Aged
(3)
Antigens
(3)
Antineoplastic Agents - Therapeutic Use
(3)
Biological And Medical Sciences
(3)
Cancer Therapies
(3)
Cytotoxicity
(3)
Immunology
(3)
Immunotherapy
(3)
Lung Cancer
(3)
Lymphocytes
(3)
Melanoma
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Driven by Mutations: The Predictive Value of Mutation Subtype in EGFR-Mutated Non–Small Cell Lung Cancer

Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

A Natural Language Processing-Assisted Extraction System for Gleason Scores: Development and Usability Study

Targeting PD-L1 for non-small-cell lung cancer

Referral practices of medical oncologists to palliative care for patients with metastatic non-small cell lung cancer (NSCLC)

Immunotherapy in melanoma

PS01.03: Referral Practices of Medical Oncologists to Palliative Care for Patients with Metastatic Non–Small Cell Lung Cancer (NSCLC)

PS01.03: Referral Practices of Medical Oncologists to Palliative Care for Patients with Metastatic Non–Small Cell Lung Cancer (NSCLC): Topic: Medical Oncology

Effectiveness of First-line Immune Checkpoint Blockade Versus Carboplatin-based Chemotherapy for Metastatic Urothelial Cancer

Palliative Care Referrals for Advanced Non–small-cell Lung Cancer (NSCLC): Patient and Provider Attitudes and Practices

Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer

A phase II study of talazoparib and avelumab in VHL deficient clear cell renal cell carcinoma

Emerging role of nivolumab in the management of patients with non-small-cell lung cancer: current data and future perspectives

Real-world trends in first-line checkpoint inhibitor use (CPI) in advanced urothelial cell carcinoma (aUC)

Burden of genetic testing in an academic biobank by pathological and family history-based criteria in prostate cancer (PCa)

Carboplatin-based chemotherapy (C) versus immunotherapy (IO) in metastatic urothelial carcinoma (mUC)

A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer

Sequencing Treatment in BRAFV600 Mutant Melanoma: Anti-PD-1 Before and After BRAF Inhibition

STUDIES ON CHOLINESTERASE

STUDIES ON CHOLINESTERASE

Rate of penetration of electrolytes into nerve-fibers

Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution

Evaluation of Sustained Virologic Response as a Relevant Surrogate Endpoint for Long-term Outcomes of Hepatitis C Virus Infection

Ombitasvir, paritaprevir, and ritonavir plus dasabuvir for 8 weeks in previously untreated patients with hepatitis C virus genotype 1b infection without cirrhosis (GARNET): a single-arm, open-label, phase 3b trial

PO-653-08 EFFECT OF VT ABLATION ON TIME BETWEEN VT STORM AND HEART TRANSPLANT

Suchergebnisse filtern